Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
51.06 USD | +0.64% | -3.99% | +16.17% |
Apr. 15 | Morgan Stanley Raises Price Target on Ovintiv to $53 From $49, Keeps Equalweight Rating | MT |
Apr. 12 | Ovintiv Maintained at Buy at TPH Ahead of Q1 Results; Price Target at US$66.00 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.17% | 13.64B | |
+7.92% | 294B | |
+5.45% | 146B | |
+55.38% | 128B | |
+18.26% | 80.27B | |
+8.93% | 74.75B | |
+19.98% | 62.53B | |
+8.37% | 57.13B | |
+10.34% | 48.14B | |
+27.26% | 34.96B |
- Stock Market
- Equities
- OVV Stock
- News Ovintiv Inc.
- Ovintiv Maintained at Buy at TPH Ahead of Q1 Results; Price Target at US$66.00